Cyrus Biotechnology to Present Its Novel IgG-degrading IdeS Enzyme Development Candidates for Autoimmune Indications at PepTalk Conference in San Diego

Director of Discovery Dr. Erik Procko recently performed a presentation on Cyrus’ novel IgG-degrading IdeS enzyme development candidates at PepTalk Conference San Diego on January 16th. The article can be found via the following link:

https://www.businesswire.com/news/home/20240116136157/en/Cyrus-Biotechnology-to-Present-Its-Novel-IgG-degrading-IdeS-Enzyme-Development-Candidates-for-Autoimmune-Indications-at-PepTalk-Conference-in-San-Diego/

Share this post